Ebselen for Severe COVID-19

"Considering the fact that Ebselen is only in its second phase of clinical trials, our team at Power gauged the medication's safety to be a 2 on the scale from 1-3. Thus far, there are some data points affirming security but none indicating effectiveness."

"Currently, 7 medical centres are running the trial; these include Winston-Salem, Dallas and Kansas City as well as other locations. It is suggested that interested participants choose a centre near their residence in order to reduce time spent travelling."

"Currently, this medical research is not in the recruitment phase. It was initially published on August 27th 2021 and most recently modified on November 4th 2022. If you are seeking other trials, there are 1,739 studies actively looking for participants with coronavirus infections and an additional four investigation sites admitting patients to study Ebselen's efficacy."

"Ebselen has been studied since 2021, beginning with a Phase 1 study sponsored by Sound Pharmaceuticals that included 50 patients. Following successful results from this initial trial, Ebselen was granted its drug approval and currently there are 4 active studies taking place in 23 cities across 2 countries."

"As per clinicaltrials.gov, this medical experiment is not currently open for enrollment. The trial was initially posted on August 27th 2021 and last modified on November 4th 2022. While the study isn't welcoming participants presently, there are an abundance of alternative trials with active recruitment campaigns ongoing at present."

"Presently, there are 4 active clinical trials for Ebselen, with 1 study in Phase 3. The bulk of the research is taking place in Durham, North carolina; however, 39 other locations have launched their own experiments into this drug's efficacy."